Nevro Corp
NYSE:NVRO

Watchlist Manager
Nevro Corp Logo
Nevro Corp
NYSE:NVRO
Watchlist
Price: 5.84 USD Market Closed
Market Cap: $221.2m

Operating Margin

-18.7%
Current
Declining
by 1.5%
vs 3-y average of -17.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-18.7%
=
Operating Income
$-76.5m
/
Revenue
$408.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-18.7%
=
Operating Income
$-76.5m
/
Revenue
$408.5m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Nevro Corp
NYSE:NVRO
220.9m USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
134.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...

Market Distribution

Lower than 76% of companies in the United States of America
Percentile
24rd
Based on 14 112 companies
24rd percentile
-18.7%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Nevro Corp
Glance View

Market Cap
221.2m USD
Industry
Health Care

Nevro Corp. engages in the provision of medical devices. The company is headquartered in Redwood City, California and currently employs 945 full-time employees. The company went IPO on 2014-11-06. The firm has developed and commercialized the Senza spinal cord stimulation (SCS) system. SCS is a neuromodulation platform for the treatment of chronic pain, with the Senza Omnia platform, which is in addition to the Senza family of products. The Company’s solution for chronic pain includes 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain based on what it believes to be the best clinical evidence available. The advantages of its 10 kHz Therapy over traditional SCS include demonstrated superior efficacy data for both leg and back pain, paresthesia free pain relief for patients, anatomical lead placement for physicians, and ability to treat a broader group of chronic pain patients.

NVRO Intrinsic Value
9.02 USD
Undervaluation 35%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-18.7%
=
Operating Income
$-76.5m
/
Revenue
$408.5m
What is Nevro Corp's current Operating Margin?

The current Operating Margin for Nevro Corp is -18.7%, which is below its 3-year median of -17.2%.

How has Operating Margin changed over time?

Over the last 3 years, Nevro Corp’s Operating Margin has increased from -23.5% to -18.7%. During this period, it reached a low of -33.3% on Jun 30, 2022 and a high of 0.6% on Mar 31, 2023.

Back to Top